Kent Lake Capital LLC cut its holdings in Bioventus Inc. (NYSE:BVS – Free Report) by 48.5% during the fourth quarter, according to its most recent Form 13F filing with the SEC. The firm owned 532,880 shares of the company’s stock after selling 502,288 shares during the period. Kent Lake Capital LLC owned 0.68% of Bioventus […]
Canaccord Genuity Group upgraded shares of Bioventus (NYSE:BVS – Free Report) from a hold rating to a buy rating in a research note issued to investors on Thursday, Benzinga reports. The firm currently has $7.00 price objective on the stock, up from their prior price objective of $3.66. A number of other equities research analysts […]
Bioventus (NYSE:BVS – Get Free Report) is set to announce its earnings results before the market opens on Tuesday, November 7th. Analysts expect the company to announce earnings of $0.06 per share for the quarter. Bioventus has set its FY 2023 guidance at -$0.24–$0.20 EPS.Investors that are interested in registering for the company’s conference call […]
Bravura Solutions Limited (ASX:BVS – Get Free Report) insider Andrew Russell purchased 67,565 shares of the stock in a transaction dated Thursday, September 21st. The stock was acquired at an average cost of A$0.74 ($0.47) per share, for a total transaction of A$49,998.10 ($32,050.06). Bravura Solutions Price Performance The company has a debt-to-equity ratio of […]
Bravura Solutions Limited (ASX:BVS – Get Free Report) insider Andrew Russell bought 67,565 shares of the business’s stock in a transaction that occurred on Thursday, September 21st. The shares were acquired at an average price of A$0.74 ($0.47) per share, for a total transaction of A$49,998.10 ($32,050.06). Bravura Solutions Stock Performance The company has a […]